Quality of life issues are increasingly being recognized as critical in the spectrum of cancer treatment that the prolongation of survival cannot be the only therapeutic objective. In some cases, patients and physicians may have to choose between the prospects of longer survival or better quality of life during the remaining time.
Patients and methods: This is a cross sectional study carried out to measure health-related quality of life in 275 women with breast cancer attending Al-Basrah oncology center during six months period, data were collected through direct interview using the standard European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-C30) and its complementary questionnaire specific for breast cancer (QLQ -BR -23).
Results: The study showed that the mean score for global QoLwas52.39 ±17.1 indicating that the patients had average scale score. The most important predictors of global QoL were physical, role, cognitive and sexual functions in addition to future perspective and arm symptoms.
The most important determinants predicting global QOL were role, physical, cognitive and sexual functions in addition to future perspective and arm symptoms.